Path: utzoo!utgpu!jarvis.csri.toronto.edu!rutgers!uwm.edu!zaphod.mps.ohio-state.edu!usc!ucla-cs!Ken.Green@p5.f180.n221.z1.fidonet.org
From: Ken.Green@p5.f180.n221.z1.fidonet.org (Ken Green)
Newsgroups: sci.med.aids
Subject: drugs
Message-ID: <31763@shemp.CS.UCLA.EDU>
Date: 10 Feb 90 20:18:19 GMT
Sender: news@CS.UCLA.EDU
Organization: FidoNet node 1:221/180.5 - QuickBBS Canada Her, Kitchener ON
Lines: 27
Approved: aids@cs.ucla.edu
Archive-number: 1698

The following excerpts appeared in PMAC Advertising Supplement:

"Another product of biotechnology recently introduced in Canada is
recombinant erythropeoitin, a natural human hormone which stimulates the
production of red blood cells in bone marrow to treat leukaemia resulting
from kidney failure.  Future applications could include treatment of
anaemia in other conditions such as rheumatoid arthritis, cancer and Aids."

has anyone had any experience with this ?  with what results ?

The article goes on to say :

"Worldwide, some 80 medicines using genetic engineering are under
development by the pharmaceutical industry.  Cancer is the main focus of
biotechnology research, with 45 products being tested for cancer or
cancer-related conditions.  There are 14 products being tested for AIDS or
Aids-related illnesses.  Twelve vaccines are being tested for hepatitis B,
malaria and the AIDS virus.  Major categories of biotechnology products in
development include monoclonal antibodies (21), vaccines (12), interleukins
(9) and interferons (8)."

can anyone tell me the name of the vaccines currently being tested for
Aids?

--  
Uucp: ...{gatech,ames,rutgers}!ncar!asuvax!stjhmc!221!180.5!Ken.Green
Internet: Ken.Green@p5.f180.n221.z1.fidonet.org